Overview

Miglustat on Gaucher Disease Type IIIB

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
evaluate the combination therapy with Miglustat and enzyme replacement therapy (ERT) on Gaucher disease
Phase:
N/A
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborator:
Actelion
Treatments:
1-Deoxynojirimycin
Miglustat